Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
15000 participants
OBSERVATIONAL
2013-01-01
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
NCT05752604
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
NCT06779747
Observational Study on Thyroid Tumors and EvaLuation of the roLe of New pOntential Predictive/Prognostic Factors
NCT07064369
Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer
NCT01074684
PET-TC in Thyroid Evaluation
NCT06852144
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients diagnosed with thyroid cancer
Patients with histologically-confirmed diagnoses of papillary, follicular, Hürthle, poorly differentiated, anaplastic, or medullary thyroid cancer
Standard treatment
e.g., surgery, radioiodine therapy, systemic treatments (multikinase inhibitors), surveillance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard treatment
e.g., surgery, radioiodine therapy, systemic treatments (multikinase inhibitors), surveillance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinical follow-up including serum thyroglobulin (Tg) assays, circulating Tg antibodies, and high-resolution gray-scale and color Doppler US of the thyroid bed and cervical lymph node compartments. Additional imaging studies and/or fine-needle aspiration biopsy for cytology are ordered at the examiner's discretion in accordance with evidence-based guidelines
* entire follow-up at a participating clinical center.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Italian Thyroid Cancer Observatory (ITCO) Foundation
UNKNOWN
Catholic University of the Sacred Heart
OTHER
University of Roma La Sapienza
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sebastiano Filetti
Full Professor of Internal Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sebastiano Filetti, MD
Role: PRINCIPAL_INVESTIGATOR
Full professor of Internal Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
A.S.S.T. Grande Ospedale Metropolitano Niguarda
Milan, Milano, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Milano, Italy
IRCCS Ospedale San Raffaele
Milan, Milano, Italy
Ospedale Regina Apostolorum
Albano Laziale, RM, Italy
Ospedali Riuniti di Ancona
Ancona, , Italy
Università degli Studi di Bari
Bari, , Italy
Ospedale degli Infermi di Biella
Biella, , Italy
Azienda Unità Sanitaria di Bologna - Ospedale Maggiore
Bologna, , Italy
University of Bologna, S. Orsola Malpighi Hospital
Bologna, , Italy
Università degli Studi di Brescia, Spedali Civili
Brescia, , Italy
Azienda Ospedaliero-Universitaria di Cagliari
Cagliari, , Italy
Azienda Ospedaliero Universitaria "Mater Domini" di Catanzaro
Catanzaro, , Italy
Azienda Ospedaliero Universitaria di Ferrara
Ferrara, , Italy
University of Florence
Florence, , Italy
Ente Ospedaliero Ospedali Galliera
Genova, , Italy
Sapienza University of Rome, Santa Maria Goretti Hospital
Latina, , Italy
Tinchi Pisticci Hospital
Matera, , Italy
Azienda Ospedaliera Universitaria "Gaetano Martino"
Messina, , Italy
Università degli Studi di Milano, Istituto Auxologico
Milan, , Italy
University of Modena and Reggio Emilia
Modena, , Italy
University of Naples Federico II
Napoli, , Italy
Azienda Ospedale-Università Padova
Padua, , Italy
Istituto Oncologico del Veneto IRCCS
Padua, , Italy
University of Parma
Parma, , Italy
Istituti Clinici Scientifici Maugeri
Pavia, , Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, , Italy
Bio-Medical Campus University
Roma, , Italy
IRCCS Istituti Fisioterapici Ospitalieri - IFO - Istituto Regina Elena
Roma, , Italy
Sapienza University of Rome, Sant'Andrea Hospital
Roma, , Italy
Sapienza University of Rome
Rome, , Italy
A.O.U. Ruggi d'Aragona
Salerno, , Italy
University of Siena
Siena, , Italy
AOU Città della Salute e della Scienza
Torino, , Italy
University of Turin, Gradenigo Hospital
Torino, , Italy
Azienda Sanitaria Universitaria Friuli Centrale
Udine, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Marco Boniardi, MD
Role: primary
Maura Arosio, MD
Role: primary
Andrea Giustina, MD
Role: primary
Rinaldo Guglielmi, MD
Role: primary
Augusto Taccaliti, MD
Role: primary
Francesco Giorgino, M.D.
Role: primary
Vincenzo Triggiani, M.D.
Role: backup
Anna Nelva, MD
Role: primary
Erica Solaroli, M.D.
Role: primary
Alessandra Sforza, M.D.
Role: backup
Uberto Pagotto, MD
Role: primary
Francesco Dondi, MD
Role: primary
Francesco Boi, MD
Role: primary
Antonio Brunetti, MD
Role: primary
Maria Chiara Zatelli, MD
Role: primary
Luisa Petrone, MD
Role: primary
Arnoldo Piccardo, MD
Role: primary
Marco Centanni, MD
Role: primary
Antonella Carbone, MD
Role: primary
Guido Fadda, MD
Role: primary
Laura Fugazzola, MD
Role: primary
Bruno Madeo, MD
Role: primary
Domenico Salvatore, MD
Role: primary
Caterina Mian, MD
Role: primary
Stefania Zovato, MD
Role: primary
Graziano Ceresini, MD
Role: primary
Mario Rotondi, MD
Role: primary
Alessandro Antonelli, MD
Role: primary
Anna Crescenzi, MD
Role: primary
Marialuisa Appetecchia, MD
Role: primary
Salvatore Monti, MD
Role: primary
Mario Vitale, MD
Role: primary
Maria Grazia Castagna, MD
Role: primary
Emanuela Arvat, MD
Role: primary
Barbara Puligheddu, MD
Role: primary
Fabio Vescini, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Lamartina L, Grani G, Arvat E, Nervo A, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Massa M, Bellantone R, Pontecorvi A, Montesano T, Pagano L, Daniele L, Fugazzola L, Ceresini G, Bruno R, Rossetto R, Tumino S, Centanni M, Meringolo D, Castagna MG, Salvatore D, Nicolucci A, Lucisano G, Filetti S, Durante C. 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr Relat Cancer. 2018 Mar;25(3):L7-L11. doi: 10.1530/ERC-17-0453. Epub 2017 Nov 30. No abstract available.
Lamartina L, Durante C, Lucisano G, Grani G, Bellantone R, Lombardi CP, Pontecorvi A, Arvat E, Felicetti F, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Crocetti U, Montesano T, Giubbini R, Orlandi F, Aimaretti G, Monzani F, Attard M, Francese C, Antonelli A, Limone P, Rossetto R, Fugazzola L, Meringolo D, Bruno R, Tumino S, Ceresini G, Centanni M, Monti S, Salvatore D, Spiazzi G, Mian C, Persani L, Barbaro D, Nicolucci A, Filetti S. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory. Thyroid. 2017 Dec;27(12):1490-1497. doi: 10.1089/thy.2017.0299. Epub 2017 Nov 10.
Grani G, Zatelli MC, Alfo M, Montesano T, Torlontano M, Morelli S, Deandrea M, Antonelli A, Francese C, Ceresini G, Orlandi F, Maniglia CA, Bruno R, Monti S, Santaguida MG, Repaci A, Tallini G, Fugazzola L, Monzani F, Giubbini R, Rossetto R, Mian C, Crescenzi A, Tumino D, Pagano L, Pezzullo L, Lombardi CP, Arvat E, Petrone L, Castagna MG, Spiazzi G, Salvatore D, Meringolo D, Solaroli E, Monari F, Magri F, Triggiani V, Castello R, Piazza C, Rossi R, Ferraro Petrillo U, Filetti S, Durante C. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients. Thyroid. 2021 Feb;31(2):264-271. doi: 10.1089/thy.2020.0272. Epub 2020 Jul 1.
Forleo R, Grani G, Alfo M, Zilioli V, Giubbini R, Zatelli MC, Gagliardi I, Piovesan A, Ragni A, Morelli S, Puxeddu E, Pagano L, Deandrea M, Ceresini G, Torlontano M, Puligheddu B, Antonelli A, Centanni M, Fugazzola L, Spiazzi G, Monti S, Rossetto R, Monzani F, Tallini G, Crescenzi A, Sparano C, Bruno R, Repaci A, Tumino D, Pezzullo L, Lombardi CP, Ferraro Petrillo U, Filetti S, Durante C, Castagna MG. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid. 2021 Dec;31(12):1814-1821. doi: 10.1089/thy.2021.0248. Epub 2021 Oct 20.
Grani G, Gentili M, Siciliano F, Albano D, Zilioli V, Morelli S, Puxeddu E, Zatelli MC, Gagliardi I, Piovesan A, Nervo A, Crocetti U, Massa M, Sama MT, Mele C, Deandrea M, Fugazzola L, Puligheddu B, Antonelli A, Rossetto R, D'Amore A, Ceresini G, Castello R, Solaroli E, Centanni M, Monti S, Magri F, Bruno R, Sparano C, Pezzullo L, Crescenzi A, Mian C, Tumino D, Repaci A, Castagna MG, Triggiani V, Porcelli T, Meringolo D, Locati L, Spiazzi G, Di Dalmazi G, Anagnostopoulos A, Leonardi S, Filetti S, Durante C. A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study. J Clin Endocrinol Metab. 2023 Jul 14;108(8):1921-1928. doi: 10.1210/clinem/dgad075.
Related Links
Access external resources that provide additional context or updates about the study.
ITCO Foundation homepage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3366
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.